Copyright
©The Author(s) 2004.
World J Gastroenterol. Aug 1, 2004; 10(15): 2223-2227
Published online Aug 1, 2004. doi: 10.3748/wjg.v10.i15.2223
Published online Aug 1, 2004. doi: 10.3748/wjg.v10.i15.2223
Table 3 HCV NS5A and p21 promoter activity
| Group | Relative luciferase activity | F | P |
| pwwp-luc (1.0 µg) | 0.44 × 105 | 0.52 | > 0.05 |
| + pCNS5A (0.5 µg) | 0.46 × 105 | ||
| + pCNS5A (1.0 µg) | 0.43 × 105 | ||
| pwwp-luc (1.0 µg) | 0.56 × 105 | 28.16 | < 0.01 |
| + pC53-NS (0.5 µg) | 2.68 × 105 | ||
| + pC53-NS (1.0 µg) | 4.84 × 105 |
- Citation: Gong GZ, Jiang YF, He Y, Lai LY, Zhu YH, Su XS. HCV NS5A abrogates p53 protein function by interfering with p53-DNA binding. World J Gastroenterol 2004; 10(15): 2223-2227
- URL: https://www.wjgnet.com/1007-9327/full/v10/i15/2223.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i15.2223